Similar to other lysosomal storage disorders, genetic, epigenetic, and environmental factor including race, ethnicity, gender, and polymorphisms in other genes (angiotensin-converting enzyme (ACE), alpha-actinin-3 (ACTN3)) have been suggested to affect the onset and progression of Pompe disease [2]. The gene discussed is ACTN3; the disease is lysosomal storage disease.